RxDoctor Payments Data

Murray Ehrinpreis

Gastroenterology · Detroit, MINPI 1972540979

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 102 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by AbbVie at 36.7% of the total. Reporting peaked in 2019 at $846 and has fallen 73.0% since, to $228 in 2022. That places this record below the midpoint for gastroenterology clinicians in MI, where the typical reported total is $1,620.

$1,799in general payments, 2019–2025

Across 102 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$659
  • Gilead$398
  • Takeda Pharmaceuticals U.S.A., Inc.$210
  • Pfizer$89
  • Johnson & Johnson$74
  • AstraZeneca$73
  • plus $296 from 11 others

What the payments were for

  • Food & beverage$1,799100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,799 in reported general payments places this provider in the 50th percentile of 497 gastroenterology providers in Michigan.

See all gastroenterology providers in Michigan →

Other gastroenterology in Detroit

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →